Skip to main content
OpenTrials

Clinical trial condition

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis

Explore clinical trials studying Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis. Study availability and eligibility vary by location and protocol.

82 public trials 16 recruiting studies
Refine in advanced search Browse all conditions

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis trial results

Completed

Phase II Study on Gusperimus in Patients With Refractory Wegener's Granulomatosis

NCT00530075

Conditions
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Cardiovascular Diseases, +12 more
Locations
  • General Faculty Hospital Prague, Czechia
  • Reumatologisk Klinik Copenhagen, Denmark
  • Universitatsklinikum Schleswig-Holstein Lübeck, Germany
  • University Hospital Maastricht Maastricht, Netherlands
View Trial Details
Completed

Abatacept in Treating Adults With Mild Relapsing Wegener's Granulomatosis

NCT00468208

Conditions
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Cardiovascular Diseases, +16 more
Locations
  • The Johns Hopkins Vasculitis Center Baltimore, Maryland, United States
  • Boston University School of Medicine Boston, Massachusetts, United States
  • Mayo Clinic College of Medicine Rochester, Minnesota, United States
  • Cleveland Clinic Cleveland, Ohio, United States
View Trial Details
Completed

Anti-Cytokine Therapy for Vasculitis

NCT00753103

Conditions
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Brain Diseases, +19 more
Locations
  • University Hospitals Birmingham NHS Foundation Trust Birmingham, West Midlands, United Kingdom
View Trial Details

Related conditions